Principles and Tools for Selection of Umbilical Cord Blood and Unrelated Adult Donor Grafts

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1 SUPPL., 2008, Pages 112-119

  Lee, Stephanie J ^a   Kamani, Naynesh ^b   Confer, Dennis L ^c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL MARROW DONOR PROGRAM   (United States)

Author keywords

HLA matching; Umbilical cord blood; Unrelated hematopoietic cell donors

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLELE; ARTICLE; CHRONIC MYELOID LEUKEMIA; COMPUTER PROGRAM; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; GENE LOCUS; GRAFT FAILURE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MYELODYSPLASTIC SYNDROME; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

ADULT; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; SOFTWARE; TRANSPLANTATION IMMUNOLOGY;

EID: 37349102353     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.11.009     Document Type: Article

References (37)

1. Confer D.L., and Miller J.P. Optimal donor selection: beyond HLA. Biol Blood Marrow Transplant 13 (2007) 83-86
2. Lee S.J., Klein J., Haagenson M., et al. High resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood (2007) (in press)
3. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104 (2004) 1923-1930
4. Morishima Y., Sasazuki T., Inoko H., et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 99 (2002) 4200-4206
5. Petersdorf E.W., Hansen J.A., Martin P.J., et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 345 (2001) 1794-1800
6. Petersdorf E.W., Smith A.G., Mickelson E.M., et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 81 (1993) 1923-1932
7. Shaw B.E., Gooley T., Madrigal J.A., Malkki M., Marsh S.G., and Petersdorf E.W. Clinical importance of HLA-DPB1 in haematopoietic cell transplantation. Tissue Antigens 69 Suppl 1 (2007) 36-41
8. Shaw B.E., Marsh S.G., Mayor N.P., Russell N.H., and Madrigal J.A. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 107 (2006) 1220-1226
9. Petersdorf E.W., Longton G.M., Anasetti C., et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR-identical unrelated donor marrow transplantation. Blood 86 (1995) 1606-1613
10. Petersdorf E.W., Longton G.M., Anasetti C., et al. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci USA 93 (1996) 15358-15363
11. Petersdorf E.W., Gooley T.A., Anasetti C., et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92 (1998) 3515-3520
12. Petersdorf E.W., Anasetti C., Martin P.J., et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 104 (2004) 2976-2980
13. Sasazuki T., Juji T., Morishima Y., et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 339 17 (1998) 1177-1185
14. Kawase T., Morishima Y., Matsuo K., et al. High-risk HLA allele mismatch combinations responsible for severe acute graft versus host disease and implication for its molecular mechanism. Blood (2007) (in press)
15. Petersdorf E.W., Kollman C., Hurley C.K., et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood 98 (2001) 2922-2929
16. Kollman C., Howe C.W., Anasetti C., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98 (2001) 2043-2051
17. Kurtzberg J., Laughlin M., Graham M., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335 (1996) 157-166
18. Barker J.N., Davies S.M., DeFor T., Ramsay N.K., Weisdorf D.J., and Wagner J.E. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97 (2001) 2957-2961
19. Eapen M., Rubinstein P., Zhang M.J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369 (2007) 1947-1954
20. Laughlin M.J., Barker J., Bambach B., et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344 (2001) 1815-1822
21. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
22. Rocha V., Cornish J., Sievers E.L., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97 (2001) 2962-2971
23. Gluckman E., and Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol 18 (2006) 565-570
24. Kernan N., Carter S.L., Wagner J.E., et al. Umbilical cord blood transplantation in pediatric patients: results of the prospective, multi-institutional Cord Blood Transplantation Study (COBLT). Biol Blood Marrow Transplant 12 (2006) 14-15
25. Kogler G., Enczmann J., Rocha V., Gluckman E., and Wernet P. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 36 (2005) 1033-1041
26. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
27. Kurtzberg J., Carter S.L., Wagner J.E., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with leukemia. Submitted (2007)
28. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord blood transplantation from unrelated and related donors. N Engl J Med 337 (1997) 373-381
29. Rubenstein P., Carrierm C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
30. Wagner J., Rosenthal J., Sweetman R., et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88 (1996) 795-802
31. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100 (2002) 1611-1618
32. Migliaccio A.R., Adamson J.W., Stevens C.E., Dobrila N.L., Carrier C.M., and Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 96 (2000) 2717-2722
33. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
34. Gluckman E., Rocha V., Arcese W., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 32 (2004) 397-407
35. Hurley C.K., Lowe L.A.B., Logan B., et al. National Marrow Donor Program: HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant 9 (2003) 610-615
36. Maiers M., Gragert L., and Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Human Immunol 68 (2007) 779-788
37. Bone Marrow Donors Worldwide. http://www.bmdw.org. Leiden, The Netherlands; 2007.